Specific immune response to mRNA vaccines against COVID-19 in patients receiving allogeneic stem cell transplantation for myeloid malignancy was altered by immunosuppressive therapy

BACKGROUND: Allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients are at high risk of complications associated with COVID-19 infection due to dysfunction of their immune system. Vaccination can protect from the adverse consequences of COVID-19. However, studies on the efficacy of COVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Macková, Jana, Hainz, Petr, Kryštofová, Jitka, Roubalová, Kateřina, Šťastná-Marková, Markéta, Vaníková, Šárka, Musil, Jan, Vydra, Jan, Němečková, Šárka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188197/
https://www.ncbi.nlm.nih.gov/pubmed/37216792
http://dx.doi.org/10.1016/j.leukres.2023.107314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188197/
https://www.ncbi.nlm.nih.gov/pubmed/37216792
http://dx.doi.org/10.1016/j.leukres.2023.107314

Ejemplares similares